Premium
Defining a responder in treatment trials for chronic idiopathic constipation
Author(s) -
Raja S.,
Ford A. C.
Publication year - 2011
Publication title -
alimentary pharmacology and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.308
H-Index - 177
eISSN - 1365-2036
pISSN - 0269-2813
DOI - 10.1111/j.1365-2036.2010.04504.x
Subject(s) - medicine , tegaserod , placebo , adverse effect , tolerability , number needed to treat , constipation , randomized controlled trial , chronic constipation , lubiprostone , clinical trial , relative risk , confidence interval , alternative medicine , pathology